Producing next generation infusion technology for an improved patient experience. We innovate in the field of infusion care both independently and in cooperation with our trusted partners.1
Reliability
Our lasting relationships with existing partners and our commitment to quality are proof that we are devoted to building strong partnerships. We believe transparency and proactivity are essential for productive relationships.
Proven technology
Our infusion sets have wide usage* and are tested for diabetes, Parkinson’s disease, pain management and primary immunodeficiency*. Decades of experience back up our expertise. *Please refer to the Instructions For Use (IFU) to read more about the indications for use and other relevant information.
Stable delivery
We deliver more than 110 million products each year with a solid and established supply chain.3
Manufacturing excellenceResponding to strong demandQualitySustainability
Contact™ Detach
Manual insertion. 90° insertion angle. Stainless steel cannula. Disconnect at separate site...
Convatec expands support for people living with advanced Parkinson’s disease
Convatec Group Plc (LSE:CTEC), a FTSE 100 global medical devices and technologies
company focused on solutions for the management of chronic conditions...
Convatec partners with Beta Bionics on innovative iLet™ Bionic Pancreas System
Convatec Group Plc (LSE:CTEC), a FTSE 100 global medical products and technologies
company focused on solutions for the management of chronic conditions..
Convatec Expands Unomedical Manufacturing Technology Partnership with Medtronic Diabetes to Meet Growing Demand
Convatec Group Plc (“Convatec”), a leading global medical products and technologies company, today announced an expansion of its manufacturing technology platform for the insulin pump therapy business at Medtronic.